We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT05213104
Brief Title: Assessment of Flecainide to Lower the Patent Foramen Ovale Closure Risk of Atrial Fibrillation or Tachycardia (AFLOAT)

First Submitted : December 20, 2021
First Submitted that Met QC Criteria : January 14, 2022
First Posted : January 28, 2022

Last Update Submitted that Met QC Criteria : September 6, 2022
Last Update Posted : September 7, 2022